Indena buys into Thorne as it targets US supplements-pharma niche

By Shane Starling

- Last updated on GMT

Indena buys into Thorne as it targets US supplements-pharma niche

Related tags: Nutrition

Italian botanical extracts giant Indena has gained an undisclosed shareholding in US supplements manufacturer, Thorne Research, that will see the two working to expand their presence in areas like cancer and diabetes.

Christian Artaria, Indena's Milan-based marketing director and head of functional food development, told NutraIngredients the partnership was a natural progression because the two firms had been working together over many years.

“It will have little impact on our relationship with other customers because we are targeting very specific areas, particularly the practitioner channel and these indications of cancer and diabetes,” ​he said.

“Thorne has been a preferred customer of ours for many years and we are both interested in the borderline between supplements and pharmaceuticals, to help people with these pathologies.”

The partnership will see Indena offering its patented extracts to Thorne for research and development in the practitioner area, and this work will itself build on the collaboration Thorne entered into in 2010 with Swiss player, Helsinn Pharmaceuticals.

Indena has also committed to providing data and information about its extracts (non-generic) to the medical portal, Healthelements.com.

“Through this collaboration we will work to develop a new generation of high-quality supplements with remarkable safety and efficacy profiles that will help people improve their health and quality of life,”​ said Indena general manager, Daniele Giavini in a statement.

Thorne CEO Paul Jacobson added:“Indena shares our commitment to improving health, and we expect that this effort will lead to many important advances in supplements based on botanicals and other nutritional products in diverse areas of health including cancer support, diabetes, cardiovascular disease and nervous system disorders in the years ahead.”

In an interview​ with NutraIngredients-USA.com this year, Jacobson observed that 80-90% of cancer patients take food supplements.

Related news

Show more

Related products

show more

SABINSA: COMMITTED TO SCIENCE, NATURE, AND HEALTH

SABINSA: COMMITTED TO SCIENCE, NATURE, AND HEALTH

SABINSA | 01-Aug-2019 | Technical / White Paper

Since 1988 Sabinsa has amplified the wisdom of the past using modern science, technology, and quality standards. The founder’s belief that sustainable...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars